NASDAQ
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) has a free cash flow growth of -91.00% as of Friday, May 29, 2026. This represents a 123.60% decrease compared to its 12-month average of 385.59%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.